On August 16, 2023, ImpediMed Limited announced the Company?s board recommended the shareholders to vote against the shareholder proposals for the removal of Donald Williams, Amit Patel, David Anderson and Daniel Sharp and the appointment of McGregor Grant, Christine Emmanuel-Donnelly, Andrew Grant and Janelle Delaney as the director of the Company at the General Meeting of shareholders of the Company scheduled to be held on September 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.086 AUD | -3.37% | -4.44% | -40.69% |
05:03am | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
Apr. 17 | Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.69% | 118M | |
+8.69% | 220B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 107B | |
+0.27% | 63.05B | |
+12.72% | 51.74B | |
+3.96% | 50.47B | |
+0.40% | 40.91B | |
+15.03% | 40.59B |
- Stock Market
- Equities
- IPD Stock
- News ImpediMed Limited
- ImpediMed Limited Shareholders Received a Letter from the Board